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THiE application of the methods of urinary cholesterol estimation given by
Burchell and Maclagan (1949) to cancer and control cases will now be described.
BMATERIAL
Urine specimens were obtained from 13 normal subjects and 116 patients
admitted to Westminster Hospital or to Westminster Hospital (.All Saints')
Urological Centre. Twenty-five of these patients were suffering from diseases
thought to be unlikely to affect cholesterol excretion as shown in the tables, and
73 were suffering from various forms of cancer. The remaining 18 were patients
suffering from haematuria or pyuri3 ofnon-malignant origin. The diagnosis in
the cancer group was established in most caes by laparotomy (3), biopsy (38)
or autopsy (12), but in 20 cases the diagnosis was based on unequivocal X-ray
or other clinical data.
Collection and treatment of specimens.
Preliminary results having shown that a considereble amount of cholesterol
might be associated with the urinary sediment in certain cases, a routine pro-
cedure was adopted to standardize the treatment of the sediment.
Twelve-hour specimens of urine were collected into clean winchesters, the
time ofthe collection being usually between the hours of 6 p.m. and 6 a.m.
The volume of specimen was measured, the urine adjusted to pHE 5-0 with
acetic acid and, if urates were present, warmed to 37° C. Cell counts on the
urinary depo/it (UD) were carried out by the method ofAddis (1925) on a 10 ml.
portion of the well-mixed specimen. For cholesterol estimation on the deposit
a 500 ml. sample of the mixed specimen, or a smaller aliquot in the case of a
concentrated urine, was centrifuged, the deposit washed once with normal saline
and extracted directly with three portions of boiling acetone. The acetone
extract was evaporated to dryness, and the residue extracted with petroleum
ether for the determination of cholesterol as above.
The cholesterol content of the supernatant urine (SU) was determined on
200 ml. portions by the aluminium tungstate method described by Burchell and
Maclagan (1949). For urines containing much protein smaller volumes were
taken according to the amount ofprotein present.URINARY CHOLESTEROL EXCRETION IN CAN-CER PATIENTS
RESULTS.
Con trol s.ibjccts.
The cholesterol contenit of the Sil_per?iataut ari,ie in 23 control subjects is
-hown in Fig. 1. These subjects included 9 normal persons and 14 patients
convalescent from diseases thought to be unlikelv to affect cholesterol excretion.
~uch as hernia. appendicitis. fractures. etc.
It appears from this that the upper normal limit may be taken as 30-5 mrg.
per 12 hours. and that there is no significant difference between the range of
excretion in mien and women.
The cholesterol content and cell counts of the ,?riary d6posit in 24) control
subjects is shown in Fig. 2. These subjects included 9 normial persons and 11
convalescent patients as above.
Fi,:. 1. tCoLAe_-t-rLl,-ntent. Supernatant urine. Twentv-th-re- ncormal an.d ,ntr,l -ubj -ts.
It will be seen from this that the normal range both for cholesterol and for
cell counts is higher for women than for men. presumably on account of the
grreater cellularity of the deposit from women. The upper normial limits for
cholesterol were (-(i3 nicr. per 12 hours for men and -1442 mg. for women. It
w-ill be noted that our figures for the normal cell counts are higher than those
given by Addis (1926). The sex difference is mainly due to the larger number of
epithelial cells and leucocytes in urinary deposits froim w omen. It appears
likely from these figures that the total urinar- cholesterol would not exceed
4-49 mg. per 12 hours by our method. but as a result of our finding on the UD
cholesterol we did not studv total urinary cholesterol in normal subjects.
AIf-l ,??iMIt lrZ(a.
The association of albuminuria with increased cholesterol excretion is illus-
trated in Fig. 3.
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It is evident from this that if albuminuria is present from whatever cause,
the SU may be expected to show an increase in cholesterol content, and such a
rise is unlikely to be specifically related to cancer. On the other hand, 4 patients
excreted small amounts of protein without increased cholesterol. The correla-
tion between urinary protein and cholesterol is definite, but not very close.
Obviously the plasma cholesterol would influence this correlation, but no plasma
cholesterol estimations were done on these patients.
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FIG. 2.-Cholesterol content of urinary deposits. Twenty normal and control cases.
x - x Leucocytes.
(o 0 Red blood cells.
* 0 Epithelial cells.
Haematuria and pyuria.
Similarly, any patient with haematuria or pyuria may be expected to show
an increase in the UD cholesterol as shown in Table I.
Inthis group ofcases anattempt was madeto correlate the cholesterol content
of the UD) with quantitative cell counts, andalthough no exact correlation could
be established, it will be noted that the three highest cholesterol values were
associated with the highest cell counts. Pyuria was the commonest accompani-
ment ofraised UD cholesterol in this series, but increase in red cells and epithelial
cells appear to be significant in cases No. 137 and 152.
It is evident from these results that a careful examination of the urinary
deposit must accompany any cholesterol estimation if the result is to be
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FIG. 3.-SU cholesterol in 17 cases ofalbninuria.
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TABLE I.-Cholee,rol Content of Urinary Dposit in Case of
Haematuria and Pyuria.
Diagnos/
Enlarged prostate.
Carcinoma ofbladder
Cystitis
Carcinoma ofbladder
Ulcer of toe .
T.B. cystitis
Chronic nephritis .
Appendicectomy
Carcinoma ofbladder
Choesterl
(mg per
12 hmurs).
23-4
6-35
4-35
3-10
1-02
0-98
0-79
0-72
0-71
0-48
Leumocytes (mHlism per
12 hours).
6,100
314
1,420
207
129
100
164
1-7
196
213
Red bkod cets Epitl cels
(mions per (nuflio per
12 hom). 12 hours).
5,500 . 0
12,700 . 0
380 . 0
92 . 0-24
197 . 0
0 . 5-90
0 .0
4-4 . 0
0 . 2-84
0-17
interpreted intelligently. Unless specimens are quite fresh, there is also the
possible danger ofdecomposition and solution ofblood cells to be considered.
Cancer.
The cholesterol content of the supernatant urine in 51 cases of various types
of cancer is shown in Fig. 4, and full details of these patients are given in Table
II. In these cases absence of albnminuria and pyuria was established by appro-
priate tests in each case.
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Case
No.
151
157
165
166
161
152
156
137
144
119
T
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It will be seen that only two cases were significantly above the normal level
of 0.5 mg. per 12 hours, one case of carcinoma of oesophagus (No. 42, 0.68 mg.)
and one of osteogenic sarcoma (No. 88, 0.73 mg.). There were three cases at
border-line level (0-51-0.53 mg.), including one case of carcinoma of uterus,
one ofrectum and one ofpenis.
The cholesterol and cell content of the urinary deposit in 24 cases of cancer
without albuminuria, haematuria or gross pyuria are shown in Fig. 5. Full
details of these patients are given in Table III.
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FIG. 4.-Cholesterol content ofsupernatant urine in 51 cancer cases. Albuminuria and
pyuria excluded.
For the purpose of this table any leucocyte count in excess of 100 millions
per 12 hours has been excluded. It will be seen from this table that no case
showed cholesterol values significantly above the normal limits, although a
marked sex difference is again obvious.
The UD cholesterol results in 4 cases of cancer with haematuria or pyuria
(leucocyte counts above 100 millions per 12 hours) were shown in Table I, but
it will be seen that the high values here were equally distributed between cancer
and non-cancer cases, and were presumably due simply to an increase in cell
content.
The cholesterol content of the supernatant urine in 11 cancer cases before
and after treatment are shown in Table IV.
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Fi5. 5.-Cholesterol content of urinar-deposits in 24 cancer eases. Albuminuria and pyuria excluded
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TABLE H.-Cholesterol Content of Supernaant Urine in Cancer Patients.
Albuminuria and Pyuria Excluded.
Case No. Sex. : coesterol per129 hours.
88 . M . . Osteogenic sarcoma . . . . .. 0-73
42 . M. . Careinoma of oesophagus . . . . . 0 68
72 . M. . ,, penis . . . . 0-53
34 . F. . ,, uterus . . . . . . 0 52
73 . M. . ,, rectum .. ... 0-51
19 . F. . ,, breast, bone metastase . . . 0-48
78 . F. ,, cervix . . . . . . 0-47
77 . M. . ,, bladder . . . . . 0-42
15 . M . ,, bronchus . . . 0-. . 42
82 . F . ,, breast, metastases in lung . . 0 41
89 . F . ,, breast and secondaries . . . 0- 38
31 . F. . ,, colon . . . . . . 0-37
14 . F. . Lymphadenoma . . . . . . 0-33
48 . M. . Osteogenic saro ma . . . . . . 0 33
71 . F. . Careminoma ofbreast . . . . . . 0-33
92 . M. . Lymphadenoma . . . . . O- 32
28 . F. . Carcinoma ofcolon . . . . . . O 30
40b . M. . bronchus . . . . . 028
98 . F. . Fungating carcinoma of breast . . . . 0-28
80 . F. . Carcinoma ofbreast . . . . . . 0-26
55 . M. . Fibrosarcoma of calf . 0-25
17 . F. . Secondary deposits after melanoma . . . 0-23
105 . M. . Carcinoma of bronchus . . . . . 0-23
26 . F. . ,, rectum . . 0-22
41 . F. ,, uterus, secondaries of ilium m . 0-22
65 . F . ,, breast . . ... 0-22
87 . F. .2 ,, . 021
94 . M. . Sarcoma ofthigh . . . .. 0-21
21 . M. . Carcinomatous peritonii . . . . . 0-20
27 . F. . Carcinoma ofoesophags . . . . . 0- 20
83 . F. . Paget's diseaseofnipple . . . . . 0- 20
40a . M. . Carcinoma ofstomach . . . . . 0-19
96 . M. . Rodent oftemporal region . . . . 0-19
22 . M. . Carcinoma ofbronchus . . . . . 0-17
25 . M . ,, oesophagus . . . . . 0-17
29 . F. . Primary carcinoma of rectum, multiple secondaries 0-17
62 . F. . Carcinoma ofbreast and secondaries . . . 0-17
106 . M. . Rodent ulcer . . . . . . . 0-17
108 . F. . Epithelioma ofear . . . . . . 0-17
18 . F. . Secondaries in spine from carcinoma of breast . 0-16
104 . F. . Carcinoma of breast and secondaries . . . 0-16
30 . M . ,, palate, tonsil and pharynx . . 0-15
95 . M. . ,, larynx . . . . . . 0-15
43 . F. . ,, breast and gl . . . . 0-11
75 . M. . ,, parotid gland. 0-. . . . 11
52 M. . ,, oesophagus . . . . . 0-09
10 . M. . Multiple secondaries . . . . . . 0- 08
13 . M. . Carcinoma ofstomach . . . . . 0-07
20 . M. . Secondary deposits after melanoma . . . 0-05
107 . M. . Epithelioma of vocal cord and arytenoid process . 0
61 . F. . Carcinoma of ovary . . . . . . 0
It will be seen that there was no constant change, 7 case' showing a rise and
4 showing a fall after treatment. All values are within normal limits.
Pr9teose and cholesterol content of #upernatant urines.
The relationship between the SU cholesterol and SU proteose for 14 control
and 53 cancer cases is shown in Fig. 6.URINARY CHOLESTEROL EXCRETION LN CANCER PATIENTS
TABLE III.-Cholesterol Content of Urinary Deposits in Cancer Cases.
Albuminuria and Pyuria Excluded.
Diagnosis.
Carceinoma of ovary
breast, secondary deposit
stomach
Paget's disease of nipple
Carcinoma of breast. Secondaries
Fungating carcinoma of breast
Carcinoma of breast
,, uterus..
,, breast, secondary offemui
,, cervix .
,, breast .
,, rectum -.
,, breast, metastases in lung
Anal careminoma .
Malignant tumour of tibia
Lymphadenoma
Multiple metastases .
Carcinoma oftonsillar fossa and palat4
,, lung .
`, stomach
Leukoplakiak
Sareooma ofthigh
Osteogenic sarcoma
Mg. Leucocytes Red blood
cholesterol (millions mels per 12 hrs. per 12 hrs.). (mlper 12 hrs).
0-34 . 28-0 . 0
s 0-31 .
0-27 . 5-06 . 0
0-23 . - .
0-18 . 58-50 0
. 0-17 .
. 0-17 . 3-16 . 0
0-15 .
r 0-09 . 11-7 . 0
0-08 . 42-5 . 0
0-06
0-05 . 6-2 . 1-46
0-03 g 0 -03 . . 0 . 0 . 0
0 . 19-5 . 0
. 0-07 . 2-6 . 0-20
. 0-04 .
0 . 6-15 . 0
0 . 0 . 0
0O 22-2 9 0
0 . 0-59 . 0
0 . 6-85 0
0
0 . -
In cases where cell countsarenotshown,theurinarydeposit showed absenceofabnormal constituents.
TABLE IV.-Compartson of Cholesterol Contents of Supernatant Urine in
11 Cancer Patients Before and After Treatment.
Diagnosis
Carcinoma of breast
Osteogenic sarcoma
Sarcoma of thigh
Carcinoma of larynx .
uterus
Rodent ulcer
Carcinoma of bronchus
Rodent ulcer
Epithelioma of right ear
Fungating carcinoma ofbreast
Carcinoma of breast . .
Cbolesterol (m& per 12 brs.).
Treatment. Before After
treatment. treatment.
Irradiation . 0-33 0-06
,, . 0-73 0-15
,, . 0-21 0-34
,, . 0-15 <0-10 ~,, . 0-51 0-37
,, . 0-19 0-43
,., . 0-23 0-38 ~,, . 0-17 0-19
0-17 0-20
Radical mastectomy . 0-28 0-37
Testosterone . 0-16 0-38
The proteose content of these urines was determined by treating the washed
aluminium tungstate precipitate from 5 ml. of urine with phenol reagent as
described by Burchell and Maclagan (1949), where reasons are given for assuming
that this method does, in fact, estimate a proteose-like substance.
It will be seen from Fig. 6 that there is veryv little correlation between proteose
and cholesterol, although the few cases outside normal limits with both estima-
tions are cancer cases. Thus accepting the normal limits shown in Fig. 6, all
7 cases with high cholesterol values and all 4 cases with high proteose values
were suffering from cancer. However, only 2 of these cases had both proteose
and cholesterol above normal.
4
Case Sex No.
136
90
124
83
118
98
133
97
131
117
87
125
82
114
122
134
92
121
130
116
142
123
99
88
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
F.
M.
M.
M.
M.
M.
M.
M.
M.
M.
Epithelial cells
(millons per12hrs.).
4-50
. 3-68
. 0-27
. 4-44
2-0
0
0-88
. 4-55
. 0-34
0
0-13
. 0-17
0
. 0-13
0-38
Case
No.
71
88
94
95
97
96
105
106
108
98
104
Sex.
F.
M.
M.
M.
F.
M.
M.
M.
F.
F.
F.
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DISCUSSION.
One ofthe principalresults ofthis study is to emphasize the essentialdifference
between the nature of the cholesterol in the urinary deposit (UD) and in the
supernatant urine (SU). The UD cholesterol is associated with the cells of the
deposit and shows a marked sex difference, being much higher in women than in
men. It appears to have no direct relation to cancer. The SU cholesterol on
the other hand is associated with a urinary proteose fraction, or with heat-
coagulable protein when present. Raised SU cholesterol excretion in the
absence of albuminuria did occur in a small proportion of cases of cancer (5 out
of 51 cases), although the increase was slight in 3 of these cases. This gives a
total incidence of hypercholesteroluria in cancer of 9-8 per cent, which is some-
what lower than that reported by other workers. Thus Sobotka, Bloch and
Rosenbloom (1940) found 20-6 per cent, and Bruger and Ehrlich (1943) 34-3 per
cent of positive results. Our highest values for total urine cholesterol in control
subjects are about 0-9 mg. per 12 hours, and correspondapproximately to those
given by Sobotka, Bloch and Rosenbloom for pooled specimens on non-cancer
subjects (up to 0-5 mg. per litre). They are, however, appreciably lower than
Bruger and Ehrlich's normal upper limit of 3-88 mg. per 24 hours.
It is evident that the accidental inclusion of cases with albuminuria or pyuria
is a great danger in this work, as the former will cause a rise in the SU cholesterol,
and the latter a rise in the LU) cholesterol. We feel therefore that urinary
cholesterol values are difficult to interpret without quantitative data on urine
protein and deposit, and it is possible that the omission of this precaution by
other workers may explain the apparent discrepancy between their results and
ours. Forexample,Bruger and Ehrlich (1943) reported some rise oftotal urinary
cholesterol in 11 out of 32 cases of cancer, but 5 of these had either albuminuria
or excess of cells in the deposit or both, findings which, according to our expe-
rience, might have been sufficient to account for the hypercholesteroluria even
in the absence of cancer. The exclusion ofthese cases would bring the incidence
of positive results down to the figure of 22-2 per cent., which does not differ
significantly from our own finding of 9-8 per cent (difference 12-4, standard error
of difference 8-2).
We must conclude, therefore, that hypercholesteroluria, while frequently
due to associated albuminuria or pyuria, does occur in a small proportion of
cases of cancer in the absence of these factors. In such cases it is the super-
natant urine cholesterol which is increased. The incidence is not high enough
to make the estimation of any diagnostic value, but it is of theoretical interest,
and presumably depends upon increased tissue breakdown as suggested by
previous workers. It should be noted that the colorimetric method of estima-
tion used is not entirely specific for cholesterol, and the possibility that other
steroids might have given rise to the few positive results must be admitted.
However, the earlier work of Bloch and Sobotka (1938) on pooled 100 litre
specimens of urine suggests that the results probably were due to increase of
cholesterol itself.
The question of urinary proteose is of some interest in view of the work of
Winzler and Burk (1943) on blood proteose and cancer in rats. Our observations
on the urinary proteose estimated by the aluminium tungstate method include
4 cases of cancer with high urinary proteose values. This is again a smallURINARY CHOLESTEROL EXCRETION IN CANCER PATIENTS 51
proportion of the 53 cases tested. Only two of these patients also had high
urinary cholesterol excretion, so that there appears to be an occasional associa-
tion between cancer and urinaryproteose, which is independent ofcholesteroluria.
Presumably this phenomenon also depends upon increased tissue breakdown in
the tumour tissue.
SUMMARY.
1. Values are given for the 12-hourly excretion of urinary cholesterol in 38
control subjects and in 73 patients suffering from various forms of cancer.
2. The cholesterol in the urine deposit (UD) normally varies from 0-0-05 mg.
per 12 hours in men, and from 0-0-42 mg. in women. The supernatant urine
cholesterol (SU) varies from 0-0-5 mg. per 12 hours with no sex difference.
3. Albuminuria if present increases the SU cholesterol, haematuria or pyuria
increases the UD cholesterol.
4. In 51 cases of cancer without albuminuria the SU cholesterol was above
normal in 5, 3 ofthese cases having only slightly raised values.
5. In 24 cases of cancer without haematuria or pyuria the UD cholesterol
was within normal limits.
6. In 53 cases of cancer without albuminuria, the SU proteose was above
normal in 4 cases.
This work was aided by a grant from the British Empire Cancer Campaign
to Westminster Hospital. We are also indebted to the medical and surgical
staff at the hospital for permission to investigate their patients.
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